PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WES vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between WES and ABBV is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

WES vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Western Midstream Partners, LP (WES) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
2.26%
4.59%
WES
ABBV

Key characteristics

Sharpe Ratio

WES:

2.26

ABBV:

0.46

Sortino Ratio

WES:

3.17

ABBV:

0.73

Omega Ratio

WES:

1.39

ABBV:

1.11

Calmar Ratio

WES:

2.89

ABBV:

0.58

Martin Ratio

WES:

11.24

ABBV:

1.45

Ulcer Index

WES:

5.16%

ABBV:

7.60%

Daily Std Dev

WES:

25.69%

ABBV:

23.69%

Max Drawdown

WES:

-93.66%

ABBV:

-45.09%

Current Drawdown

WES:

-0.06%

ABBV:

-13.89%

Fundamentals

Market Cap

WES:

$15.54B

ABBV:

$310.22B

EPS

WES:

$3.91

ABBV:

$2.86

PE Ratio

WES:

10.44

ABBV:

61.38

PEG Ratio

WES:

5.48

ABBV:

0.41

Total Revenue (TTM)

WES:

$2.68B

ABBV:

$41.23B

Gross Profit (TTM)

WES:

$1.57B

ABBV:

$30.76B

EBITDA (TTM)

WES:

$1.68B

ABBV:

$17.62B

Returns By Period

In the year-to-date period, WES achieves a 6.25% return, which is significantly higher than ABBV's -1.21% return. Over the past 10 years, WES has underperformed ABBV with an annualized return of 3.96%, while ABBV has yielded a comparatively higher 15.15% annualized return.


WES

YTD

6.25%

1M

2.69%

6M

2.26%

1Y

56.07%

5Y*

25.15%

10Y*

3.96%

ABBV

YTD

-1.21%

1M

1.26%

6M

4.59%

1Y

11.00%

5Y*

19.25%

10Y*

15.15%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WES vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WES
The Risk-Adjusted Performance Rank of WES is 9494
Overall Rank
The Sharpe Ratio Rank of WES is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of WES is 9393
Sortino Ratio Rank
The Omega Ratio Rank of WES is 9191
Omega Ratio Rank
The Calmar Ratio Rank of WES is 9595
Calmar Ratio Rank
The Martin Ratio Rank of WES is 9393
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 6464
Overall Rank
The Sharpe Ratio Rank of ABBV is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 5656
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 6060
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 7373
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 6565
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

WES vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Western Midstream Partners, LP (WES) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for WES, currently valued at 2.19, compared to the broader market-2.000.002.002.190.46
The chart of Sortino ratio for WES, currently valued at 3.09, compared to the broader market-4.00-2.000.002.004.003.090.73
The chart of Omega ratio for WES, currently valued at 1.38, compared to the broader market0.501.001.502.001.381.11
The chart of Calmar ratio for WES, currently valued at 2.80, compared to the broader market0.002.004.006.002.800.58
The chart of Martin ratio for WES, currently valued at 10.89, compared to the broader market0.0010.0020.0010.891.45
WES
ABBV

The current WES Sharpe Ratio is 2.26, which is higher than the ABBV Sharpe Ratio of 0.46. The chart below compares the historical Sharpe Ratios of WES and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00AugustSeptemberOctoberNovemberDecember2025
2.19
0.46
WES
ABBV

Dividends

WES vs. ABBV - Dividend Comparison

WES's dividend yield for the trailing twelve months is around 7.84%, more than ABBV's 3.58% yield.


TTM20242023202220212020201920182017201620152014
WES
Western Midstream Partners, LP
7.84%8.33%8.52%6.80%5.69%11.25%12.45%8.25%5.44%4.04%3.86%1.73%
ABBV
AbbVie Inc.
3.58%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

WES vs. ABBV - Drawdown Comparison

The maximum WES drawdown since its inception was -93.66%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for WES and ABBV. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-0.06%
-13.89%
WES
ABBV

Volatility

WES vs. ABBV - Volatility Comparison

Western Midstream Partners, LP (WES) has a higher volatility of 6.10% compared to AbbVie Inc. (ABBV) at 5.32%. This indicates that WES's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
6.10%
5.32%
WES
ABBV

Financials

WES vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Western Midstream Partners, LP and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab